Kitov receives notice regarding minimum bid requirements

|About: Kitov Pharma Ltd (KTOV)|By:, SA News Editor

On July 8, 2019, Kitov Pharma (NASDAQ:KTOV) received a non-compliance letter from Nasdaq, due to the Company's current share price.

The Company's continued listing on the Nasdaq is contingent on regaining compliance during the 180-day period, ending on January 6, 2020.

Subscribe for full text news in your inbox